Safety & Effectiveness of Autologous Regenerative Cell Therapy on Pain & Inflammation of Osteoarthritis of the Shoulder (NCT02844738)
Safety and Effectiveness of Autologous Regenerative Cell Therapy on Pain and Inflammation Associated With Osteoarthritis of the Shoulder
🩺 Plain-English Summary (8th-Grade Level)
This is a prospective open-label clinical study of 50 patients to determine safety and treatment potential of autologous cell therapy for pain and inflammation associated with Osteoarthritis of the shoulder. Follow-up will consist of a larger sample including 4,000 patients.
Who can join: Review the eligibility criteria below.
Location: VivaTech International, Inc. — Grove City, Pennsylvania
Age range: 18 Years to 90 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (1 Sites)
- VivaTech International, Inc. — Grove City, Pennsylvania
📞 Contact the Study Coordinator
Phone: (855) 984-8287
Email: scott.herkes@gmail.com
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Osteoarthritis
- FORCE-TJR: Improving Orthopedic Outcomes Through a National TJR Registry — Worcester, Massachusetts
- Outcomes Study of the Trabecular Metal (TM) Reverse Shoulder System — San Francisco, California
- Preoperative Correction of Vitamin D Deficiency in Total Joint Arthroplasty (TJA) — Miami, Florida
- Persona Partial Knee Clinical Outcomes Study — Fremont, California
- Evaluation of Biomarkers in Human Synovial Fluid — Durham, North Carolina
- Comprehensive Nano - Post Market Clinical Follow-Up Study — Graz, Styria
Explore by condition: All Osteoarthritis clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.